Updated:
Fusion Pharma
Fusion Pharma is a company founded in 2013 in London, England. It specializes in regulatory affairs for the pharmaceutical sector. The firm provides...
Fusion Pharma
Fusion Pharma is a company founded in 2013 in London, England. It specializes in regulatory affairs for the pharmaceutical sector. The firm provides consultancy services in product licensing, quality assurance, pharmacovigilance, and medical activities.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Stockholm
Corporate office
Stockholm, Canada
Sector focus
Frequently asked questions
What does Fusion Pharma actually do?
The firm's name and Saskatchewan location point toward pharmaceutical procurement or investment, but no public disclosures confirm its activities. It may focus on drug supply-chain solutions for rural Canadian healthcare providers, though this remains unverified. Without a website, LinkedIn presence, or trade-publication coverage, its operating model is unknown.
Who runs Fusion Pharma?
No named principals are publicly associated with Fusion Pharma. The firm has no website, no LinkedIn page, and no mentions in Saskatchewan business journals or pharmaceutical industry directories. Leadership remains undisclosed as of mid-2026.
Where is Fusion Pharma headquartered?
The firm's registered address is in Stockholm, Saskatchewan—a small rural community in Canada's prairie region. Stockholm has a population of approximately 350 people, making this an unusual base for a pharmaceutical investment entity compared to major Canadian healthcare hubs.
Does Fusion Pharma disclose its assets under management?
No. Fusion Pharma does not publicly report AUM, deal volume, or deployment figures. No regulatory filings in Canada's SEDAR+ system or provincial securities databases have been linked to this entity.
Is Fusion Pharma a venture firm, a family office, or an operating company?
The firm's structure is not publicly documented. Its name suggests an operating or investment focus on pharmaceuticals, but no corporate filings confirm whether it operates as an asset manager, a family office, a holding company, or a compounding pharmacy. Without disclosures, its legal form remains unconfirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: